GI Toxicity | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
Parameter | Hz | 95% CI | p-value | Hz | 95% CI | p-value |
Age | 0.93 | 0.89-0.97 | <0.001* | 0.99 | 0.93-1.04 | 0.584 |
Performance status | 1.67 | 0.73-3.85 | 0.227 | 1.84 | 0.70-4.82 | 0.218 |
Comorbidity | 1.18 | 0.75-1.86 | 0.482 | 0.88 | 0.62-1.77 | 0.878 |
Smoking | 1.05 | 0.62-1.77 | 0.853 | 0.71 | 0.51-1.58 | 0.708 |
3DCRT vs IG-IMRT | 12.81 | 7.84-20.92 | <0.001* | 11.59 | 6.67-20.14 | <0.001* |
Adjuvant ADT | 0.31 | 0.16-0.60 | 0.001* | 0.27 | 0.13-0.56 | <0.001* |
GU toxicity | Univariate analysis | Multivariate analysis | ||||
Parameter | Hz | 95% CI | p-value | Hz | 95% CI | p-value |
Age | 1.00 | 0.97-1.04 | 0.869 | 1.01 | 0.97-1.05 | 0.476 |
Performance status | 1.80 | 0.99-3.24 | 0.052 | 1.68 | 0.89-3.18 | 0.111 |
Comorbidity | 1.50 | 1.07-2.11 | 0.018* | 1.50 | 1.02-2.21 | 0.038* |
Smoking | 1.27 | 0.89-1.81 | 0.185 | 1.28 | 0.88-1.88 | 0.200 |
3DCRT vs IG-IMRT | 1.58 | 1.10-2.26 | 0.013* | 1.72 | 1.11-2.67 | 0.015* |
Adjuvant ADT | 0.60 | 0.34-1.06 | 0.078 | 0.57 | 0.30-1.06 | 0.075 |